إسرائيل - العبرية - Ministry of Health

teva pharmaceutical indust.ltd - metformin hydrochloride 850 mg - tablets - metformin - metformin teva is indicated in diet - failed non - insulin dependent diabetic patients especially if overweight either alone as initial therapy or in combination with a sulfonylurea. occasionally as adjuvant therapy in insulin - dependent diabetic patients particularly who are usually obese and not well controlled with insulin.

إسرائيل - العبرية - Ministry of Health

teva medical marketing ltd. - coagulation factor viii recombinant 250 iu/vial - powder for solution for injection - coagulation factor viii - the use of recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).recombinate is also indicated in the perioperative management of patients with haemophilia a. recombinate is appropriate for use in children of all ages including the newborn. (safety and efficacy studies have been performed in both previously treated and previously untreated children). the product in not suitable for the treatment of von willebrand's disease.

إسرائيل - العبرية - Ministry of Health

teva medical marketing ltd. - coagulation factor viii recombinant 1000 iu/vial - powder for solution for injection - coagulation factor viii - the use of recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). recombinate is also indicated in the perioperative management of patients with haemophilia a. recombinate is appropriate for use in children of all ages including the newborn. (safety and efficacy studies have been performed in both previously treated and previously untreated children). the product in not suitable for the treatment of von willebrand's disease.

إسرائيل - العبرية - Ministry of Health

teva medical marketing ltd. - coagulation factor viii recombinant 500 iu/vial - powder for solution for injection - coagulation factor vii - the use of recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). recombinate is also indicated in the perioperative management of patients with haemophilia a. recombinate is appropriate for use in children of all ages including the newborn. (safety and efficacy studies have been performed in both previously treated and previously untreated children). the product in not suitable for the treatment of von willebrand's disease.

إسرائيل - العبرية - Ministry of Health

ferring pharmaceuticals ltd - urofollitrophin highly purified (hpfsh) 75 iu/vial - powder for solution for injection - urofollitropin - anovulation (including polycystis ovarian disease (pcod) in women who have been unresponsive to treatment with clomiphene citrate. controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (art) (e.g. in vitro fertilisation/embryo transfer (evf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).

إسرائيل - العبرية - Ministry of Health

perrigo israel agencies ltd - piperacillin as sodium 4000 mg; tazobactam as sodium 500 mg - powder for solution for injection - piperacillin - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. tazo-pip in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children. appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

إسرائيل - العبرية - Ministry of Health

perrigo israel agencies ltd - piperacillin as sodium 4000 mg; tazobactam as sodium 500 mg - powder for solution for injection - piperacillin - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. tazo-pip in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children. appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

إسرائيل - العبرية - Ministry of Health

vitamed ltd,binyamina - piperacillin as sodium 4 g; tazobactam as sodium 0.5 g - powder for solution for injection - tazobactam - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. tazocin in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children. appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years

إسرائيل - العبرية - Ministry of Health

pharmalogic ltd - piperacillin as sodium 2 g; tazobactam as sodium 250 mg - powder for solution for infusion - tazobactam - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. pipoeracillin/tazobactam in combination with an aminoglycoside is indicated for suspected bacterial infections in neutropenic adults or children above 2 years. appencicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

إسرائيل - العبرية - Ministry of Health

pfizer pharmaceuticals israel ltd - ampicillin as sodium 500 mg; sulbactam as sodium 250 mg - powder for solution for injection - ampicillin and enzyme inhibitor - sulbactam sodium/ampicillin sodium im/iv is indicated for the treatment of infections due to susceptible beta-lactamase producing strains of microorganisms in the following conditions: 1) skin and skin structure infections. 2) intra-abdominal infections. 3) gynecological infections.